Article references (32 references )


  1. WHO. Global action plan on HIV drug resistance 2017-2021. Accessed 18th Feburary 2019.

  2. UNAIDS. UNAIDS data 2018. Accessed 30th January 2019.

  3. HIV Gov. Global Statistics. Accessed 4th March 2019.

  4. USAID. Orphans and Vulnerable Children Affected by HIV and AIDS. Accessed 18th Feburary 2019.

  5. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatients study investigations. New England Journal of Medicine. 1998; 338: 853-860. Google Scholar

  6. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11. PubMed | Google Scholar

  7. Chaiyachatia KH, Ogbuojib O, Priceb M, Sutharc AB, Negussiec EK, Ba¨rnighausenb T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014 Mar;28 Suppl 2:S187-204. PubMed | Google Scholar

  8. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6. PubMed | Google Scholar

  9. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53(5):696-9. PubMed | Google Scholar

  10. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Accessed 18th Feburary 2019.

  11. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodriguez E et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381-96. PubMed | Google Scholar

  12. National agency for the control of AIDS. Nigeria GARPR 2015 report. Accessed 4th March 2019.

  13. Raosoft. Database web survey software for gathering information. Accessed 24th December 2017.

  14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. PubMed | Google Scholar

  15. Stern AF. The hospital anxiety and depression scale. Occup Med (Lond). 2014;64(5):393-4. PubMed | Google Scholar

  16. Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-8. PubMed | Google Scholar

  17. National agency for the control of AIDS. National HIV and AIDS Strategic Plan 2017-2021. Accessed 4th March 2019.

  18. National agency for the control of AIDS. FACT SHEET: HIV Prevention program. Accessed 15th January 2019.

  19. UNAIDS. Prevention Gap Report. Accessed 4th March 2019.

  20. Gyar SD, Reuben CR, Haruna MS. Study on the Distribution of HIV/AIDS Infections among Age Groups Attending General Hospital Toto, Central Nigeria. International Journal of Microbiology and Immunology Research. 2014;3(3):038-042. Google Scholar

  21. Miyada S, Garbin AJI, Gatto RCJ, Garbin CAS. Treatment adherence in patients living with HIV/AIDS assisted at a specialized facility in Brazil. Rev Soc Bras Med Trop. 2017;50(5):607-612. PubMed | Google Scholar

  22. Detels R1, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J et al. Effectiveness of potent Antiretroviral Therapy on time to AIDS and DEATH in men with known HIV infection. JAMA. 1998;280(17):1497-1499. PubMed | Google Scholar

  23. Kumi SM, jewell m, Hallett T, Cohen M. Treatment of HIV for the prevention of transmission in discordant couples and at the population level. Adv Exp Med Biol. 2018;1075:125-162. PubMed | Google Scholar

  24. Eller LS, Rivero-Mendez M, Voss J, Chen WT, Chaiphibalsarisdi P, Iipinge S et al. Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV. AIDS Care. 2014;26(7):795-803. PubMed | Google Scholar

  25. Ramirez-Avila L, Regan S, Giddy J, Chetty S, Ross D, Katz JN et al. Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. 2012;16(8):2226-2235. PubMed | Google Scholar

  26. Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260-5. PubMed | Google Scholar

  27. Low Y, Preud'homme X, Goforth HW, Omonuwa T, Krystal AD. The association of fatigue with depression and insomnia in HIVseropositive patients: a pilot study. Sleep. 2011;34(12):1723-1726. PubMed | Google Scholar

  28. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679-90. PubMed | Google Scholar

  29. Trotta MP, Cozzi-Lepri A, Ammassari A, Vecchiet J, Cassola G, Caramello P et al. Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. Clin Infect Dis. 2010;51(4):456-64. PubMed | Google Scholar

  30. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P et al. Self reported symptoms and medication side effects influence adherence to highly active anti-retroviral therapy in persons with HIV infection. Journal of acquired immune deficiency syndromes. 2011;28(5):445-9. PubMed | Google Scholar

  31. Abdulraheem IS, Onajole AT, Jimoh AAG, Oladipo AR. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. Journal of Public Health and Epidemiology. 2011;3(4):194-203. Google Scholar

  32. Bangsberg DR1, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-366. PubMed | Google Scholar